Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$139.39
Net Income/Share$43.78
Operating CF/Share$48.39
Free CF/Share$39.66
Cash/Share$83.63
Book Value/Share$303.76
Tangible Book/Share$291.54
Equity/Share$303.76
Interest Debt/Share$26.72
CapEx/Share$8.73
Dividend/Share$3.58
Valuation
Market Cap$81.22B
Enterprise Value$80.81B
P/E Ratio17.85P/S Ratio5.66P/OCF Ratio16.15
P/FCF Ratio19.90
P/B Ratio2.57P/TB Ratio2.57
EV/Sales5.63EV/EBITDA13.89
Graham Valuation
Graham Number$547.01
Graham Net-Net$50.63
Profitability
Earnings Yield5.60%FCF Yield5.02%ROE14.83%ROIC8.51%Return on Tangible Assets11.46%Dividend
Dividend Yield0.46%Payout Ratio8.22%Capital Allocation
CapEx/OCF18.04%
CapEx/Revenue6.26%
CapEx/Depreciation2.25
SBC/Revenue6.93%
SG&A/Revenue0.00%
R&D/Revenue41.52%
Liquidity & Solvency
Debt/Equity0.09Debt/Assets0.07Debt/Market Cap0.03
Net Debt/EBITDA-0.07
Current Ratio4.13Interest Coverage81.69xIncome Quality1.11Efficiency
Days Sales Outstanding146 days
Days Payables Outstanding163 days
Days Inventory556 days
Receivables Turnover2.50x
Payables Turnover2.24x
Inventory Turnover0.66x
Capital Structure
Tangible Assets$30.00B
Working Capital$13.65B
Invested Capital$20.03B
Intangibles/Assets3.10%